Aimrite Holdings Corporation (AIMH)
OTCMKTS · Delayed Price · Currency is USD
0.0179
-0.0001 (-0.56%)
At close: Sep 1, 2026
Aimrite Holdings Market Cap
Aimrite Holdings has a market cap or net worth of $2.39 million as of September 10, 2026. Its market cap has decreased by -60.22% in one year.
Market Cap
2.39M
Enterprise Value
n/a
Revenue
125.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
ChartMarket Cap Chart
Since June 16, 2003, Aimrite Holdings's market cap has increased from 130.07K to 2.39M, an increase of 1,737.12%. That is a compound annual growth rate of 13.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.39M | -33.70% |
| Dec 31, 2025 | 3.60M | 2,709,922.56% |
| Dec 1, 2023 | 133.00 | -99.99% |
| Dec 30, 2022 | 1.60M | -50.00% |
| Dec 30, 2021 | 3.20M | -10.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enterra | 3.22M |
| Blue Star Global | 3.16M |
| Lifeline Biotechnologies | 3.04M |
| ZhongMin Mei-Hao Holding Co | 3.00M |
| Golden Valley Development | 2.94M |
| Affiliated Resources | 2.91M |
| Oncology Pharma | 2.51M |
| Atlantica | 2.46M |